Device Companies to Participate in China Healthcare Partnership

The U.S. healthcare industry will work more closely with its Chinese counterpart under an initiative launched to improve innovation of drugs and devices in both countries through public-private partnerships. The initiative, announced last week as part of Chinese President Hu Jintao’s state visit to the U.S., includes 12 U.S. companies, six supporting organizations and government agencies from both countries. Pharmaceutical and device companies that will participate include Abbott, Johnson & Johnson and Pfizer.
Devices & Diagnostics Letter